Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 2, 2005, Pages 473-478

  Boyle, Maureen P ^a   Brewer, Judson A ^a   Funatsu, Michiyo ^b   Wozniak, David F ^b   Tsien, Joe Z ^c   Izumi, Yukitoshi ^a   Muglia, Louis J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Knockout mice

Indexed keywords

GLUCOCORTICOID RECEPTOR; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; FOREBRAIN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MAJOR DEPRESSION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIPRAMINE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; PROSENCEPHALON; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TIME FACTORS;

ANIMALIA;

EID: 12244264438     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0406458102     Document Type: Article

References (39)

1. Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C. & Cullinan, W. E. (2003) Front. Neuroendocrinol. 24, 151-180.
2. Barden, N. (2004) J. Psychiatry Neurosci. 29, 185-193.
3. O'Toole, S. M., Sekula, L. K. & Rubin, R. T. (1997) Biol. Psychiatry 42, 85-89.
4. Calfa, G., Kademian, S., Ceschin, D., Vega, G., Rabinovich, G. A. & Volosin, M. (2003) Psychoneuroendocrinology 28, 687-701.
5. Gass, P., Reichardt, H. M., Strekalova, T., Henn, F. & Tronche, F. (2001) Physiol. Behav. 73, 811-825.
6. Modell, S., Yassouridis, A., Huber, J. & Holsboer, F. (1997) Neuroendocrinology 65, 216-222.
7. Pariante, C. M. & Miller, A. H. (2001) Biol. Psychiatry 49, 391-404.
8. Caldji, C., Diorio, J. & Meaney, M. J. (2000) Biol. Psychiatry 48, 1164-1174.
9. Meaney, M. J., Diorio, J., Francis, D., Widdowson, J., LaPlante, P., Caldji, C., Sharma, S., Seckl, J. R. & Plotsky, P. M. (1996) Dev. Neurosci. 18, 49-72.
10. Anisman, H., Zaharia, M. D., Meaney, M. J. & Merali, Z. (1998) Int. J. Dev. Neurosci. 16, 149-164.
11. Schmid, W., Cole, T. J., Blendy, J. A. & Schutz, G. (1995) J. Steroid Biochem. Mol. Biol. 53, 33-35.
12. Barden, N., Stec, I. S., Montkowski, A., Holsboer, F. & Reul, J. M. (1997) Neuroendocrinology 66, 212-220.
13. Karanth, S., Linthorst, A. C., Stalla, G. K., Barden, N., Holsboer, F. & Reul, J. M. (1997) Endocrinology 138, 3476-3485.
14. Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., Bock, R., Klein, R. & Schutz, G. (1999) Nat. Genet. 23, 99-103.
15. Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R. & Tonegawa, S. (1996) Cell 87, 1317-1326.
16. Frank, E. & Thase, M. E. (1999) Annu. Rev. Med. 50, 453-468.
17. Brewer, J. A., Khor, B., Vogi, S. K., Muglia, L. M., Fujiwara, H., Haegele, K. E., Sleckman, B. P. & Muglia, L. J. (2003) Nat. Med. 9, 1318-1322.
18. Brewer, J. A., Bethin, K. E., Schaefer, M. L., Muglia, L. M., Vogt, S. K., Weninger, S. C., Majzoub, J. A. & Muglia, L. J. (2003) Stress 6, 121-125.
19. Ho, N., Liauw, J. A., Blaeser, F., Wei, F., Hanissian, S., Muglia, L. M., Wozniak, D. F., Nardi, A., Arvin, K. L., Holtzman, D. M., et al. (2000) J. Neurosci. 20, 6459-6472.
20. McEwen, B. S. (1999) Annu. Rev. Neurosci. 22, 105-122.
21. Holsboer, F. (2003) Ann. N.Y. Acad. Sci. 1007, 394-404.
22. The APA Task Force on Laboratory Tests in Psychiatry (1987) Am. J. Psychiatry 144, 1253-1262.
23. Holsboer, F. (2000) Neuropsychopharmacology 23, 477-501.
24. De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S. & Joels, M. (1998) Endocr. Rev. 19, 269-301.
25. Steckler, T., Holsboer, F. & Reut, J. M. (1999) Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 13, 597-614.
26. Holsboer, F., Lauer, C. J., Schreiber, W. & Krieg, J. C. (1995) Neuroendocrinology 62, 340-347.
27. Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J. & Weickert, C. S. (2002) Mol. Psychiatry 7, 985-994, 924.
28. DeRijk, R. H., Schaaf, M. & de Kloet, E. R. (2002) J. Steroid Biochem. Mol. Biol. 81, 103-122.
29. Agid, O., Kohn, Y. & Lerer, B. (2000) Biomed. Pharmacother. 54, 135-141.
30. Dorian, B. & Garfinkel, P. E. (1987) Psychol. Med. 17, 393-407.
31. Budziszewska, B., Jaworska-Feil, L., Kajta, M. & Lason, W. (2000) Br. J. Pharmacol. 130, 1385-1393.
32. Brady, L. S., Whitfield, H. J., Jr., Fox, R. J., Gold, P. W. & Herkenham, M. (1991) J. Clin. Invest. 87, 831-837.
33. Reul, J. M., Stec, I., Soder, M. & Holsboer, F. (1993) Endocrinology 133, 312-320.
34. Reul, J. M., Labeur, M. S., Grigoriadis, D. E., De Souza, E. B. & Holsboer, F. (1994) Neuroendocrinology 60, 509-519.
35. Langer, S. Z. & Schoemaker, H. (1988) Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 193-216.
36. Shen, C., Li, H. & Meller, E. (2002) Neuropharmacology 42, 1031-1038.
37. Porter, R. J., Gallagher, P., Watson, S. & Young, A. H. (2004) Psychopharmacology (Berlin) 173, 1-17.
38. Wei, Q., Lu, X. Y., Liu, L., Schafer, G., Shieh, K. R., Burke, S., Robinson, T. E., Watson, S. J., Seasholtz, A. F. & Akil, H. (2004) Proc. Natl. Acad. Sci. USA 101, 11851-11856.
39. McEwen, B. S. (1998) N. Engl. J. Med. 338, 171-179.